Literature DB >> 1094639

HL-A antibody response in patients with acute myelogenous leukaemia treated by immunotherapy.

T P Klouda, S D Lawler, R L Powles, R T Oliver, C K Grant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1094639     DOI： 10.1097/00007890-197503000-00008

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  6 in total

1.  Colony-forming ability of marrow from patients receiving immunotherapy during chemotherapy-induced remission in acute myeloid leukaemia.

Authors:  M Y Gordon; R L Powles; I D Douglas
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

2.  Stimulation of human lymphocytes in vitro by leucocytes from patients with untreated acute myeloid leukaemia.

Authors:  G M Taylor; S V Jones; J C Ridway; R Harris
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

3.  Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy.

Authors:  B J Chapuis; R Powles; P Alexander
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

4.  Surface antigens in acute myeloblastic leukaemia: a study using heterologous antisera.

Authors:  L Tupchong; I C MacLennan
Journal:  Br J Cancer       Date:  1978-10       Impact factor: 7.640

5.  Cytotoxic antibody in acute myeloblastic leukaemia during immunotherapy: lack of tumour specificity.

Authors:  D G Gale; I C MacLennan
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

6.  Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia.

Authors:  G M Taylor; R Harris; C B Freeman
Journal:  Br J Cancer       Date:  1976-02       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.